.

Gilead Seeks US Approval For drug That Shortens Covid Recovery Time

Gilead Sciences Inc has filed an application with the U.S. Food and Drug Administration seeking full approval for remdesivir, its experimental COVID-19 drug currently used under emergency...

from NDTV News - World-news https://ift.tt/31H4RvQ

Resent New

Discord abandons Microsoft acquisition talks: Report

Discussion platform Discord, popular among amateur video game players, has halted acquisition talks with Microsoft and is instead considerin...

Most popular News